Log in
Enquire now
F-Prime Capital Partners

F-Prime Capital Partners

F-Prime Capital Partners is a venture capital that is interested in biotechnology, enterprise, finance, financial services, fintech, health care, and pharmaceutical industries

OverviewStructured DataIssuesContributors

Contents

fprimecapital.com
Is a
Organization
Organization
Investor
Investor
Company
Company
Venture capital firm
Venture capital firm

Company attributes

Industry
Enterprise software
Enterprise software
Health information technology
Health information technology
Wealth management
Wealth management
Business development
Business development
Financial technology
Financial technology
Technology
Technology
...
Location
London
London
0
San Francisco
San Francisco
0
Cambridge, Massachusetts
Cambridge, Massachusetts
0
B2X
B2B
B2B
AngelList URL
angel.co/f-prime
Pitchbook URL
pitchbook.com/profiles...124929-64
Number of Employees (Ranges)
11 – 500
Full Address
33 Foley Street London, W1W 7TL0
1 Main St. 13th Floor Cambridge, MA 021420
116 New Montgomery Street Suite 810 San Francisco, CA 941050
Investors
‌
s20 Capital
‌
Nevcaut Ventures
‌
Ayon Capital
STCAP
STCAP
Nationwide Ventures
Nationwide Ventures
University Growth Fund
University Growth Fund
Seven Peaks Ventures
Seven Peaks Ventures
Commerce Ventures
Commerce Ventures
...
Founded Date
1946
0
Total Funding Amount (USD)
64,000,000
Latest Funding Round Date
August 2, 2021
Latest Funding Type
Series A
Series A
Wellfound ID
f-prime
Country
United States
United States
0

Venture Capital Firm attributes

Invested in
Nocion Therapeutics
Nocion Therapeutics
Pulmocide
Pulmocide
Blispay
Blispay
AvantStay
AvantStay
Zenflow
Zenflow
Simon Data
Simon Data
Vendr
Vendr
OTA Insight
OTA Insight
...

Other attributes

Company Operating Status
Active
Wikidata ID
Q30287160
Overview

F-Prime Capital is a venture capital firm in Massachusetts, United States that invests in businesses in the healthcare and technology sectors. Founded 1946 in Massachusetts, United States, this company invests in early stage, late stage venture and seed. It usually invests in Series A, Series B, Series C, Series D rounds. Its portfolio companies include Abelian Therapeutics, ABK Biomedical, Acacia Pharma, Accuri Cytometers, Adagene, Airespace, and Aclaris Therapeutics.

The firm is interested in companies that have technologies in life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. The firm is a lead investor for three investments.

F-Prime Capital is still active and as of November 2019, the company made a total of 197 investments. The company’s latest investment was on Nov 20, 2019. F-Prime Capital had 36 exits, notable of which are Precision BioSciences, ViewRay, and Kensho.

Timeline

No Timeline data yet.

Associated Investment Funds

Accelerator Batches

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like F-Prime Capital Partners

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.